STUDY OF ANTIATHEROSCLEROTIC AND ENDOTHELIOPROTECTIVE ACTIVITY OF PEPTIDE AGONISTS OF EPOR/CD131 HETERORECEPTOR

• Үндсэн зохиолчид: Olesya A. Puchenkova (Зохиогч), Sergey V. Nadezhdin (Зохиогч), Vladislav O. Soldatov (Зохиогч), Maxim A. Zhuchenko (Зохиогч), Diana S. Korshunova (Зохиогч), Marina V. Kubekina (Зохиогч), Evgeny N. Korshunov (Зохиогч), Liliya V. Korokina (Зохиогч), Polina A. Golubinskaya (Зохиогч), Aleksandr L. Kulikov (Зохиогч), Vladimir V. Gureev (Зохиогч), Vladimir M. Pokrovskiy (Зохиогч), Evgeniy A. Patrakhanov (Зохиогч), Petr R. Lebedev (Зохиогч), Tatyana A. Denisyuk (Зохиогч), Veronika S. Belyaeva (Зохиогч), Evgeniya A. Movchan (Зохиогч), Elizaveta I. Lepetukha (Зохиогч), Mikhail V. Pokrovskiy (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute, 2020-10-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Introduction. The drugs affecting a mitochondrial dysfunction, oxidative stresses, apoptosis and inflammation of the vascular wall, have a high potential for the prevention and treatment of atherosclerotic lesions. In this regard, the use of EPOR/CD131 heteroreceptor agonists which have a similar sp...